A detailed history of Amundi transactions in Boston Scientific Corp stock. As of the latest transaction made, Amundi holds 11,085,094 shares of BSX stock, worth $838 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
11,085,094
Previous 13,695,582 19.06%
Holding current value
$838 Million
Previous $792 Million 4.11%
% of portfolio
0.32%
Previous 0.36%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $150 Million - $179 Million
-2,610,488 Reduced 19.06%
11,085,094 $759 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $53.9 Million - $64.1 Million
-1,108,328 Reduced 7.49%
13,695,582 $792 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $94.6 Million - $103 Million
-1,885,154 Reduced 11.3%
14,803,910 $782 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $135 Million - $149 Million
2,721,748 Added 19.49%
16,689,064 $903 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $14.9 Million - $16.5 Million
-329,530 Reduced 2.3%
13,967,316 $699 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $43.9 Million - $52.4 Million
-1,110,502 Reduced 7.21%
14,296,846 $662 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $190 Million - $566 Million
5,164,607 Added 50.42%
15,407,348 $636 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $30 Million - $40.2 Million
852,496 Added 9.08%
10,242,741 $376 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $74.1 Million - $81.8 Million
1,812,929 Added 23.93%
9,390,245 $422 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $7.88 Million - $9.29 Million
-206,963 Reduced 2.66%
7,577,316 $338 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $61.8 Million - $68.8 Million
1,498,957 Added 23.85%
7,784,279 $338 Million
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $242 Million - $278 Million
6,285,322 New
6,285,322 $269 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $108B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.